Tumori. 2003 Jul-Aug;89(4 Suppl):56-7.

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

[Article in Italian]

Deraco M, Kusamura S, Baratti D, Casali P, Zaffaroni N.

Source

Istituto Nazionale Tumori, Milano.

Abstract

Peritoneal mesothelioma (PM) is a rare primary peritoneal tumor conditioning a very poor quality of life and prognosis. Twenty eight patients (11 men and 17 women) with PM were referred to National Cancer Institute of Milan and submitted to 29 consecutive procedures of peritonectomy and intra peritoneal hyperthermic perfusion (IPHP). Five years overall survival, disease free survival and progression free survival have been 70, 63 and 51%, respectively. Morbidity and toxicity were 14 and 21% respectively. No mortality has been observed peritonectomy associated with IPHP is an effective approach to cure patients PM.

PMID:: 12903546; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. [J Surg Oncol. 2003]
Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. J Surg Oncol. 2003 Jul; 83(3):147-53.
[Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei]. [Tumori. 2003]
[Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
Deraco M, Kusamura S, Gronchi A. Tumori. 2003 Jul-Aug; 89(4 Suppl):54-5.
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma. [J Exp Clin Cancer Res. 2003]
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
Deraco M, De Simone M, Rossi CR, Cavaliere F, Difilippo F, Scuderi S, Pilatti P, Kusamura S. J Exp Clin Cancer Res. 2003 Dec; 22(4 Suppl):41-5.
Review [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy]. [Tumori. 2003]
Review [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Costamagna D, Scuderi S, Vaira M, Barone R, De Simone M. Tumori. 2003 Jul-Aug; 89(4 Suppl):40-2.
Review Comprehensive management of diffuse malignant peritoneal mesothelioma. [Eur J Surg Oncol. 2006]
Review Comprehensive management of diffuse malignant peritoneal mesothelioma.
Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Eur J Surg Oncol. 2006 Aug; 32(6):686-91. Epub 2006 Apr 18.

See reviews... See all...

Cited by 1 PubMed Central article

Review Peritoneal mesothelioma: a review. [MedGenMed. 2007]
Review Peritoneal mesothelioma: a review.
Bridda A, Padoan I, Mencarelli R, Frego M. MedGenMed. 2007 May 10; 9(2):32. Epub 2007 May 10.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

[Peritoneal mesothelioma: results of a complicated and aggressive procedure inco...
[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].
Tumori. 2003 Jul-Aug ;89(4 Suppl):56-7.

PubMed
[A beam of dawn light of study on gossypol as a safe, effective, and reversible ...
[A beam of dawn light of study on gossypol as a safe, effective, and reversible male antifertility contraceptive--evaluation of the studies by using low dose gossypol combined with steroid hormone for male contraception].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Jun ;22(3):211-3.

PubMed
Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of pro...
Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.
Oncogene. 2003 Aug 7 ;22(32):4933-42.

PubMed
Role of radiotherapy in the treatment of neurosarcoidosis.
Role of radiotherapy in the treatment of neurosarcoidosis.
Am J Clin Oncol. 2003 Aug ;26(4):e115-8.

PubMed
Successful treatment of refractory low grade duodenal lymphoma with rituximab, a...
Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody.
Am J Clin Oncol. 2003 Aug ;26(4):408-10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information